Spire

Mepro Pharmaceuticals Pvt. Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Id: f0ff603dd2bd7fb5
Drug Approval Philippines Name: Spire
Product Name: Spire
Registration Number: DRP-4711
Brand Name: Spire
Generic Name: Spironolactone
Dosage Form: Film Coated Tablet
Dosage Strength: 50 mg
Manufacturer: Mepro Pharmaceuticals Pvt. Ltd.
Importer: MedEthix, Inc.
Distributor: MedEthix, Inc.
Issuance Date: 28 February 2022
Expiry Date: 23 October 2027
Pharmacologic Category: Antialdosterone/Renin Angiotensin Aldosterone (RAA) Modulator
Classification: Prescription Drug (RX)

Approved

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

f0ff603dd2bd7fb5

Type

Standard